Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001641172-25-018615
Filing Date
2025-07-10
Accepted
2025-07-10 17:01:19
Documents
22

Document Format Files

Seq Description Document Type Size
1 S-1/A forms-1a.htm S-1/A 667182
2 EX-4.10 ex4-10.htm EX-4.10 148226
3 EX-5.1 ex5-1.htm EX-5.1 19829
4 EX-23.1 ex23-1.htm EX-23.1 3798
5 CALCULATION OF FILING FEE TABLE ex107.htm   iXBRL EX-FILING FEES 29539
6 GRAPHIC forms-1_001.jpg GRAPHIC 71086
7 GRAPHIC forms-1_002.jpg GRAPHIC 19299
8 GRAPHIC forms-1_003.jpg GRAPHIC 21135
9 GRAPHIC forms-1_004.jpg GRAPHIC 17913
10 GRAPHIC ex5-1_001.jpg GRAPHIC 9273
11 GRAPHIC ex5-1_002.jpg GRAPHIC 4672
  Complete submission text file 0001641172-25-018615.txt   1194179

Data Files

Seq Description Document Type Size
25 EXTRACTED XBRL INSTANCE DOCUMENT ex107_htm.xml XML 8979
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

EIN.: 202903526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-288120 | Film No.: 251116893
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)